BRIEF published on 08/08/2025 at 02:20, 11 months 29 days ago CureVac Settles Patent Dispute with Pfizer/BioNTech MRNA Technology CureVac Pfizer/BioNTech Patent Resolution Vaccine Royalties
PRESS RELEASE published on 08/08/2025 at 02:15, 11 months 29 days ago CureVac Announces Resolution of Patent Litigation with Pfizer/BioNTech CureVac resolves patent litigation with Pfizer/BioNTech related to mRNA-based COVID-19 vaccines, receiving $790 million and non-exclusive license agreements BioNTech MRNA Technology CureVac Patent Litigation Pfizer
BRIEF published on 06/24/2025 at 22:14, 1 year 1 month ago CureVac publie les résultats de son assemblée générale annuelle CureVac Nominations Au Conseil D'administration Commissaires Aux Comptes Technologie De L'ARNm Assemblée Annuelle
BRIEF published on 06/24/2025 at 22:14, 1 year 1 month ago CureVac Reports Outcomes of Annual General Meeting MRNA Technology Annual Meeting Board Appointments Auditors CureVac
PRESS RELEASE published on 06/24/2025 at 22:09, 1 year 1 month ago CureVac Announces Voting Results of General Meeting CureVac announces voting results of Annual General Meeting, including new Management Board and Supervisory Board appointments. KPMG reappointed as external auditors Annual General Meeting Appointments Voting Results KPMG CureVac
BRIEF published on 05/20/2025 at 13:05, 1 year 2 months ago CureVac Reports Q1 2025 Financials and Business Developments Financial Results Revenue Patents Oncology Pipeline R&D Developments
BRIEF published on 05/20/2025 at 13:05, 1 year 2 months ago CureVac publie ses résultats financiers et ses développements commerciaux pour le premier trimestre 2025 Résultats Financiers Brevets Revenu Pipeline En Oncologie Développements En R&D
PRESS RELEASE published on 05/20/2025 at 13:00, 1 year 2 months ago CureVac Announces Financial Results for the First Quarter of 2025 and Provides Business Updates CureVac announces financial results for Q1 2025 and updates on lung cancer and glioblastoma trials, urinary tract infection vaccine, and mRNA patents. Cash position strong at €438.3 million Financial Results Oncology Pipeline CureVac Q1 2025 MRNA Patents
BRIEF published on 05/15/2025 at 22:15, 1 year 2 months ago CureVac Gains Favorable Patent Decision Against BioNTech BioNTech MRNA Technology CureVac Patent Litigation European Patent Office
BRIEF published on 05/15/2025 at 22:15, 1 year 2 months ago CureVac obtient une décision favorable en matière de brevets contre BioNTech BioNTech CureVac Technologie De L'ARNm Office Européen Des Brevets Litiges En Matière De Brevets
Published on 08/06/2026 at 14:00, 34 minutes ago Adcore to Publish Second Quarter 2026 Results on August 13, 2026
Published on 08/06/2026 at 14:00, 34 minutes ago Aeonian Reports Final Drill Results from Jake Target and Advances District-Scale Copper Exploration Model at Koocanusa
Published on 08/06/2026 at 14:00, 34 minutes ago GameSquare Signs with Azuki to Drive Creator Marketing for Gates Awakened TCG Launch and Manga Launch
Published on 08/06/2026 at 13:35, 59 minutes ago Silver X Mining Corp. Reports Record 2Q26 Revenue of $17.3M, up 29% over 1Q26, and $7.7M of First-Half Net Income
Published on 08/06/2026 at 13:30, 1 hour 4 minutes ago Nextech3D.ai Expands Enterprise Customer Base, Generating $874,000 in New Contract Value, 160 New Customer Contracts and 92% Software Gross Margins in 2026
Published on 08/06/2026 at 14:01, 33 minutes ago Original-Research: DEUTZ AG (von Quirin Privatbank Kapitalmarktgeschäft): BUY
Published on 08/06/2026 at 14:00, 34 minutes ago The NAGA Group: NuWays confirms “Buy” rating and price target of EUR 7.30
Published on 08/06/2026 at 13:00, 1 hour 34 minutes ago Fresenius transitions to registered shares – automatic conversion for shareholders
Published on 08/06/2026 at 08:44, 5 hours 49 minutes ago IDI annonce la cession du groupe Talis à son fondateur, Serge Marcillaud, accompagné de l'équipe dirigeante
Published on 08/06/2026 at 08:00, 6 hours 34 minutes ago EURAZEO ENTRE EN DISCUSSIONS EXCLUSIVES AVEC PARTNERS GROUP EN VUE DE LA CESSION DE SA PARTICIPATION DANS AROMA-ZONE ET DE SON RÉINVESTISSEMENT À SES CÔTÉS
Published on 08/06/2026 at 08:00, 6 hours 34 minutes ago EURAZEO ENTERS INTO EXCLUSIVE DISCUSSIONS WITH PARTNERS GROUP REGARDING THE CONTEMPLATED SALE OF ITS STAKE IN AROMA-ZONE AND ITS REINVESTMENT
Published on 08/06/2026 at 07:48, 6 hours 46 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 juillet 2026
Published on 08/05/2026 at 18:00, 20 hours 34 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 31 juillet 2026
